Madhumathi Palaniappan's Profile

B.Pharm

Madhumathi Palaniappan

Madhu, an alumni of Madras Medical College writes on drugs and handles the drug section on Medindia. Her long term dream and desire is to become an entrepreneur in the Pharma field.

Written / Edited / Medically Reviewed

How to Predict Autism Among High-Risk Infants

How to Predict Autism Among High-Risk Infants

Autism is a neurodevelopmental disorder that can be predicted in high-risk infants by a new neuroimaging technique.

Health Watch
New Biomarker Detects Heart Disease Risk in Lupus Patients

New Biomarker Detects Heart Disease Risk in Lupus Patients

A biomarker called High sensitivity Cardiac Troponin T (HS-cTnT) in the blood of a lupus patient, without any symptoms of heart disease, detects risk of heart attack.

Health Watch
Postmenopausal Osteoporosis: Romosozumab Drug Could Reduce Spine Fracture Risk

Postmenopausal Osteoporosis: Romosozumab Drug Could Reduce Spine Fracture Risk

Osteoporosis could weaken the bones and cause fractures. Romosozumab drug has been found to reduce the risk of spine fractures in postmenopausal osteoporosis.

Health Watch
3D-Printed Patch: Novel Approach To Treat Ischemia

3D-Printed Patch: Novel Approach To Treat Ischemia

Ischemia often occurs when the blood flow is restricted or reduced in some parts of the body. Newly designed 3-D printed patches can help to treat ischemia.

Health Watch
Arthritis Drug Could Potentially Treat Severe Heart Condition

Arthritis Drug Could Potentially Treat Severe Heart Condition

Rheumatoid arthritis drug shows promise in keeping the heart valve leaflets supple. It has potential in treating severe heart condition.

Health Watch